China Announces Training on Active Medical Device Registration and Technical Review Process in Shanghai

Details of the Update

The training session will provide guidance on registration principles and clinical evaluation requirements for several categories of active medical devices. The program will address technologies such as MRI systems, CT/X-ray equipment, nuclear medicine devices, CO₂ lasers, non-invasive brain–machine interfaces, devices with remote transmission functions, high-frequency surgical instruments for endoscopy, and aesthetic medical devices. 

The session will focus on explaining technical documentation expectations and regulatory review procedures used during the registration process in China. By outlining the regulatory framework and technical requirements, the training aims to strengthen understanding of compliance pathways for advanced medical device technologies. 

The event will be held at the Holiday Inn in Pudong New Area, Shanghai, and will target professionals from manufacturers, universities, research institutions, and hospitals involved in R&D and regulatory registration of active medical devices. It will also be relevant for regulatory affairs personnel and technical support teams responsible for managing compliance and submission processes. 

Participants can register through the WeChat application, with payment details provided in the official documentation. Electronic certificates of completion will be issued seven working days after the event. The training fee includes training materials and lunches, while accommodation is self-funded, with limited availability at preferential rates. 

Regulatory updates in China are often disseminated through WeChat, which has a broad user base and multifunctional platform capabilities that enable regulatory announcements to reach a wide audience. 

Effective Date

The technical training session on registration and clinical evaluation requirements for active medical devices will take place March 31 to April 2, 2026, at the Holiday Inn in Pudong New Area, Shanghai. 

Why It Matters

The training provides updated regulatory guidance on registration and clinical evaluation for active medical devices, supporting improved understanding of regulatory expectations in China. By clarifying technical review procedures and documentation requirements, the session may help stakeholders strengthen regulatory alignment, product development planning, and compliance preparedness while reducing potential regulatory risks.

Who This Is Relevant For

This announcement is relevant for medical device manufacturers, regulatory affairs teams, R&D departments, clinical evaluation specialists, and technical support staff involved in the development and registration of active medical devices in China. It may also benefit academic researchers and hospital teams engaged in medical device innovation and clinical evaluation activities.

Next Steps

Organizations developing or registering active medical devices should assess whether regulatory affairs and R&D teams should attend the training session to gain insights into current regulatory expectations. Stakeholders may also consider reviewing existing registration dossiers and clinical evaluation plans to ensure alignment with regulatory considerations discussed during the event. 

For companies managing regulatory obligations across multiple markets, monitoring evolving requirements and guidance can be complex. RegASK, a leading agentic AI regulatory intelligence and workflow orchestration platform, helps organizations track regulatory developments and interpret their operational impact. 

RegASK empowers global organizations in highly regulated sectors, including consumer products and life sciences, to proactively navigate complex regulatory landscapes. By combining advanced Agentic AI with experts in the loop, RegASK delivers timely predictive actionable insights and end-to-end automation, streamlining compliance processes, mitigating risks, and accelerating market access across more than 160 countries. Learn more or book a demo now. 

FAQs

What is the purpose of the training session announced by China Pharmaceutical News? 

The training aims to explain registration principles and technical review procedures for active medical devices and provide guidance on clinical evaluation and regulatory requirements in China. 

When and where will the training session take place? 

The training will be held March 31 to April 2, 2026, at the Holiday Inn in Pudong New Area, Shanghai.

Who should attend the training session? 

The session targets professionals from medical device manufacturers, universities, research institutions, and hospitals, as well as regulatory affairs and technical support teams involved in R&D or regulatory registration activities.

How can RegASK help organizations manage regulatory developments in medical device markets? 

RegASK helps organizations monitor regulatory updates, interpret evolving requirements, and coordinate compliance workflows, enabling regulatory and R&D teams to respond more effectively to regulatory changes across global markets.